Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane p24 trafficking protein 1 (TMED1) is a member of the p24 (TMED) family, a group of transmembrane proteins crucial for vesicular trafficking of membrane-bound proteins between the endoplasmic reticulum and the Golgi apparatus. TMED1 acts as a cargo receptor, facilitating the incorporation of secretory proteins into COPI and COPII-coated vesicles and may help with vesicle coat formation. It contributes to secretory pathway integrity and is widely expressed in human tissues. TMED1 has been shown to positively regulate interleukin-33 signaling through interactions with the IL1RL1 receptor and participates in innate immune signaling via the cGAS-STING pathway. Its upregulation is associated with several cancers, especially colorectal cancer, serving as both an oncogene and a poor prognosis biomarker, and knockdown experiments indicate roles in cell proliferation, apoptosis, and cell cycle regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane p24 trafficking protein 1 (TMED1).